Search research articles
Contact Us
Filters
Showing results (971-980 of 1,112) with videos related to
Page
of 112
Sort By:
Journal of Medicinal Chemistry
|
September 15, 2006
Structurally simple, potent, Plasmodium selective farnesyltransferase inhibitors that arrest the growth of malaria parasites
Matthew P Glenn, Sung-Youn Chang, Carrie Hornéy, et al.
Science Advances
|
August 2, 2024
Electrically polarized nanoscale surfaces generate reactive oxygenated and chlorinated species for deactivation of microorganisms
Annie Y Vargas-Lizarazo, M Aswad Ali, Nehal A Mazumder, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 21, 2005
A lymphotoxin-IFN-beta axis essential for lymphocyte survival revealed during cytomegalovirus infection
Theresa A Banks, Sandra Rickert, Chris A Benedict, et al.
The Journal of Infectious Diseases
|
November 21, 2022
Use of Whole-Genome Sequencing to Estimate the Contribution of Immune Evasion and Waning Immunity on Decreasing COVID-19 Vaccine Effectiveness
Margaret L Lind, Richard Copin, Shane McCarthy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 23, 2019
Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors
Aslamuzzaman Kazi, Shengyan Xiang, Hua Yang, et al.
Allergy
|
January 27, 2024
Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy
Matthew F Wipperman, Kaitlyn M Gayvert, Amanda Atanasio, et al.
Nature Communications
|
June 26, 2021
Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function
L Palanikumar, Laura Karpauskaite, Mohamed Al-Sayegh, et al.
The Lancet. Gastroenterology & Hepatology
|
September 3, 2023
Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Marc E Rothenberg, Evan S Dellon, Margaret H Collins, et al.
Journal of Medicinal Chemistry
|
September 9, 2010
Structure-based design and synthesis of potent, ethylenediamine-based, mammalian farnesyltransferase inhibitors as anticancer agents
Steven Fletcher, Erin Pusateri Keaney, Christopher G Cummings, et al.
Genetics
|
April 30, 1998
Topical reversion at the HIS1 locus of Saccharomyces cerevisiae. A tale of three mutants
R C von Borstel, E A Savage, Q Wang, et al.
Page
of 112
Search research articles
Search
Showing results (971-980 of 1,112) with videos related to
Sort By:
Page
of 112
Journal of Medicinal Chemistry
|
September 15, 2006
Structurally simple, potent, Plasmodium selective farnesyltransferase inhibitors that arrest the growth of malaria parasites
Matthew P Glenn, Sung-Youn Chang, Carrie Hornéy, et al.
Science Advances
|
August 2, 2024
Electrically polarized nanoscale surfaces generate reactive oxygenated and chlorinated species for deactivation of microorganisms
Annie Y Vargas-Lizarazo, M Aswad Ali, Nehal A Mazumder, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 21, 2005
A lymphotoxin-IFN-beta axis essential for lymphocyte survival revealed during cytomegalovirus infection
Theresa A Banks, Sandra Rickert, Chris A Benedict, et al.
The Journal of Infectious Diseases
|
November 21, 2022
Use of Whole-Genome Sequencing to Estimate the Contribution of Immune Evasion and Waning Immunity on Decreasing COVID-19 Vaccine Effectiveness
Margaret L Lind, Richard Copin, Shane McCarthy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 23, 2019
Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors
Aslamuzzaman Kazi, Shengyan Xiang, Hua Yang, et al.
Allergy
|
January 27, 2024
Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy
Matthew F Wipperman, Kaitlyn M Gayvert, Amanda Atanasio, et al.
Nature Communications
|
June 26, 2021
Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function
L Palanikumar, Laura Karpauskaite, Mohamed Al-Sayegh, et al.
The Lancet. Gastroenterology & Hepatology
|
September 3, 2023
Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Marc E Rothenberg, Evan S Dellon, Margaret H Collins, et al.
Journal of Medicinal Chemistry
|
September 9, 2010
Structure-based design and synthesis of potent, ethylenediamine-based, mammalian farnesyltransferase inhibitors as anticancer agents
Steven Fletcher, Erin Pusateri Keaney, Christopher G Cummings, et al.
Genetics
|
April 30, 1998
Topical reversion at the HIS1 locus of Saccharomyces cerevisiae. A tale of three mutants
R C von Borstel, E A Savage, Q Wang, et al.
Page
of 112